Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
0.5150
+0.0060 (1.18%)
At close: Apr 17, 2026, 4:00 PM EDT
0.5200
+0.0050 (0.97%)
After-hours: Apr 17, 2026, 7:58 PM EDT
Silo Pharma Employees
Silo Pharma had 3 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$24,034
Profits / Employee
-$1,409,233
Market Cap
8.38M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3 | 0 | - |
| Dec 31, 2024 | 3 | 0 | - |
| Dec 31, 2023 | 3 | 0 | - |
| Dec 31, 2022 | 3 | 1 | 50.00% |
| Dec 31, 2021 | 2 | 1 | 100.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 41 |
| Bolt Biotherapeutics | 23 |
| CalciMedica | 16 |
| Processa Pharmaceuticals | 12 |
| NuCana | 12 |
| Immuron | 7 |
| TransCode Therapeutics | 7 |
| Indaptus Therapeutics | 5 |
SILO News
- 12 days ago - Silo Pharma Rallies After Securing Key Patent Allowance - Benzinga
- 12 days ago - Stock Market Today: Dow, S&P 500 Futures Rise Ahead Of Trump's 'Power Plant Day' Deadline—UnitedHealth, Silo Pharma, Phillips 66 In Focus - Benzinga
- 13 days ago - Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy - GlobeNewsWire
- 7 weeks ago - Silo Pharma Announces Share Buyback Program - GlobeNewsWire
- 2 months ago - Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio - GlobeNewsWire
- 3 months ago - Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15 - GlobeNewsWire
- 5 months ago - Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD - GlobeNewsWire
- 6 months ago - Silo Pharma Selects Alphaledger's T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain - GlobeNewsWire